Luminex Corporation
Luminex Corporation (LMNX) Stock Competitors & Peer Comparison
See (LMNX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LMNX | $36.99 | +0.00% | 0 | N/A | N/A | N/A |
| ISRG | $488.61 | -2.66% | 175.1B | 68.05 | $7.18 | N/A |
| BDX | $183.63 | +0.58% | 52.6B | 35.51 | $5.17 | +2.22% |
| BDXA | $59.24 | -2.24% | 48.7B | 21.44 | $2.76 | +2.22% |
| ALC | $91.90 | -0.35% | 45.4B | 40.83 | $2.25 | +0.36% |
| RMD | $273.50 | +0.05% | 40.1B | 30.69 | $8.91 | +0.78% |
| WST | $279.10 | +22.78% | 20.1B | 44.02 | $6.36 | +0.30% |
| BAX | $28.77 | +0.74% | 14.8B | -55.37 | -$0.52 | +2.79% |
| HOLX | $66.10 | +0.23% | 14.7B | 27.77 | $2.38 | N/A |
| COO | $73.80 | +0.57% | 14.7B | 35.65 | $2.07 | N/A |
Stock Comparison
LMNX vs ISRG Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, ISRG has a market cap of 175.1B. Regarding current trading prices, LMNX is priced at $36.99, while ISRG trades at $488.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas ISRG's P/E ratio is 68.05. In terms of profitability, LMNX's ROE is +0.03%, compared to ISRG's ROE of +0.16%. Regarding short-term risk, LMNX is less volatile compared to ISRG. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check ISRG's competition here
LMNX vs BDX Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, BDX has a market cap of 52.6B. Regarding current trading prices, LMNX is priced at $36.99, while BDX trades at $183.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas BDX's P/E ratio is 35.51. In terms of profitability, LMNX's ROE is +0.03%, compared to BDX's ROE of +0.06%. Regarding short-term risk, LMNX is less volatile compared to BDX. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check BDX's competition here
LMNX vs BDXA Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, BDXA has a market cap of 48.7B. Regarding current trading prices, LMNX is priced at $36.99, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas BDXA's P/E ratio is 21.44. In terms of profitability, LMNX's ROE is +0.03%, compared to BDXA's ROE of +0.06%. Regarding short-term risk, LMNX is less volatile compared to BDXA. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check BDXA's competition here
LMNX vs ALC Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, ALC has a market cap of 45.4B. Regarding current trading prices, LMNX is priced at $36.99, while ALC trades at $91.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas ALC's P/E ratio is 40.83. In terms of profitability, LMNX's ROE is +0.03%, compared to ALC's ROE of +0.07%. Regarding short-term risk, LMNX is less volatile compared to ALC. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check ALC's competition here
LMNX vs RMD Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, RMD has a market cap of 40.1B. Regarding current trading prices, LMNX is priced at $36.99, while RMD trades at $273.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas RMD's P/E ratio is 30.69. In terms of profitability, LMNX's ROE is +0.03%, compared to RMD's ROE of +0.25%. Regarding short-term risk, LMNX is less volatile compared to RMD. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check RMD's competition here
LMNX vs WST Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, WST has a market cap of 20.1B. Regarding current trading prices, LMNX is priced at $36.99, while WST trades at $279.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas WST's P/E ratio is 44.02. In terms of profitability, LMNX's ROE is +0.03%, compared to WST's ROE of +0.24%. Regarding short-term risk, LMNX is less volatile compared to WST. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check WST's competition here
LMNX vs BAX Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, BAX has a market cap of 14.8B. Regarding current trading prices, LMNX is priced at $36.99, while BAX trades at $28.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas BAX's P/E ratio is -55.37. In terms of profitability, LMNX's ROE is +0.03%, compared to BAX's ROE of -0.08%. Regarding short-term risk, LMNX is less volatile compared to BAX. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check BAX's competition here
LMNX vs HOLX Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, HOLX has a market cap of 14.7B. Regarding current trading prices, LMNX is priced at $36.99, while HOLX trades at $66.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas HOLX's P/E ratio is 27.77. In terms of profitability, LMNX's ROE is +0.03%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, LMNX is less volatile compared to HOLX. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check HOLX's competition here
LMNX vs COO Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, COO has a market cap of 14.7B. Regarding current trading prices, LMNX is priced at $36.99, while COO trades at $73.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas COO's P/E ratio is 35.65. In terms of profitability, LMNX's ROE is +0.03%, compared to COO's ROE of +0.05%. Regarding short-term risk, LMNX is less volatile compared to COO. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check COO's competition here
LMNX vs BDXB Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, LMNX is priced at $36.99, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas BDXB's P/E ratio is 7.60. In terms of profitability, LMNX's ROE is +0.03%, compared to BDXB's ROE of +0.06%. Regarding short-term risk, LMNX is less volatile compared to BDXB. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check BDXB's competition here
LMNX vs ATR Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, ATR has a market cap of 10.7B. Regarding current trading prices, LMNX is priced at $36.99, while ATR trades at $161.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas ATR's P/E ratio is 29.52. In terms of profitability, LMNX's ROE is +0.03%, compared to ATR's ROE of +0.15%. Regarding short-term risk, LMNX is less volatile compared to ATR. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check ATR's competition here
LMNX vs MASI Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, MASI has a market cap of 8.7B. Regarding current trading prices, LMNX is priced at $36.99, while MASI trades at $161.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas MASI's P/E ratio is -29.56. In terms of profitability, LMNX's ROE is +0.03%, compared to MASI's ROE of -0.41%. Regarding short-term risk, LMNX is less volatile compared to MASI. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check MASI's competition here
LMNX vs STVN Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, STVN has a market cap of 7.6B. Regarding current trading prices, LMNX is priced at $36.99, while STVN trades at $27.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas STVN's P/E ratio is 52.67. In terms of profitability, LMNX's ROE is +0.03%, compared to STVN's ROE of +0.09%. Regarding short-term risk, LMNX is less volatile compared to STVN. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check STVN's competition here
LMNX vs RGEN Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, RGEN has a market cap of 6.8B. Regarding current trading prices, LMNX is priced at $36.99, while RGEN trades at $121.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas RGEN's P/E ratio is -290.17. In terms of profitability, LMNX's ROE is +0.03%, compared to RGEN's ROE of -0.01%. Regarding short-term risk, LMNX is less volatile compared to RGEN. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check RGEN's competition here
LMNX vs TFX Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, TFX has a market cap of 5.1B. Regarding current trading prices, LMNX is priced at $36.99, while TFX trades at $116.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas TFX's P/E ratio is 35.98. In terms of profitability, LMNX's ROE is +0.03%, compared to TFX's ROE of +0.03%. Regarding short-term risk, LMNX is less volatile compared to TFX. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check TFX's competition here
LMNX vs MMSI Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, MMSI has a market cap of 5B. Regarding current trading prices, LMNX is priced at $36.99, while MMSI trades at $84.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas MMSI's P/E ratio is 41.28. In terms of profitability, LMNX's ROE is +0.03%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, LMNX is less volatile compared to MMSI. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check MMSI's competition here
LMNX vs BLCO Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, BLCO has a market cap of 4.9B. Regarding current trading prices, LMNX is priced at $36.99, while BLCO trades at $13.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas BLCO's P/E ratio is -13.69. In terms of profitability, LMNX's ROE is +0.03%, compared to BLCO's ROE of -0.08%. Regarding short-term risk, LMNX is less volatile compared to BLCO. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check BLCO's competition here
LMNX vs HAE Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, HAE has a market cap of 3.6B. Regarding current trading prices, LMNX is priced at $36.99, while HAE trades at $74.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas HAE's P/E ratio is 22.43. In terms of profitability, LMNX's ROE is +0.03%, compared to HAE's ROE of +0.18%. Regarding short-term risk, LMNX is less volatile compared to HAE. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check HAE's competition here
LMNX vs XRAY Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, XRAY has a market cap of 3.3B. Regarding current trading prices, LMNX is priced at $36.99, while XRAY trades at $16.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas XRAY's P/E ratio is -3.68. In terms of profitability, LMNX's ROE is +0.03%, compared to XRAY's ROE of -0.38%. Regarding short-term risk, LMNX is less volatile compared to XRAY. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check XRAY's competition here
LMNX vs ICUI Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, ICUI has a market cap of 3.2B. Regarding current trading prices, LMNX is priced at $36.99, while ICUI trades at $129.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas ICUI's P/E ratio is -33.73. In terms of profitability, LMNX's ROE is +0.03%, compared to ICUI's ROE of -0.05%. Regarding short-term risk, LMNX is less volatile compared to ICUI. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check ICUI's competition here
LMNX vs WRBY Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, WRBY has a market cap of 3B. Regarding current trading prices, LMNX is priced at $36.99, while WRBY trades at $24.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas WRBY's P/E ratio is -202.92. In terms of profitability, LMNX's ROE is +0.03%, compared to WRBY's ROE of -0.04%. Regarding short-term risk, LMNX is less volatile compared to WRBY. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check WRBY's competition here
LMNX vs NNNN Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, NNNN has a market cap of 2.2B. Regarding current trading prices, LMNX is priced at $36.99, while NNNN trades at $49.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas NNNN's P/E ratio is 828.50. In terms of profitability, LMNX's ROE is +0.03%, compared to NNNN's ROE of +0.14%. Regarding short-term risk, LMNX is less volatile compared to NNNN. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check NNNN's competition here
LMNX vs LMAT Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, LMAT has a market cap of 1.8B. Regarding current trading prices, LMNX is priced at $36.99, while LMAT trades at $80.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas LMAT's P/E ratio is 41.00. In terms of profitability, LMNX's ROE is +0.03%, compared to LMAT's ROE of +0.14%. Regarding short-term risk, LMNX is less volatile compared to LMAT. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check LMAT's competition here
LMNX vs QDEL Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, QDEL has a market cap of 1.8B. Regarding current trading prices, LMNX is priced at $36.99, while QDEL trades at $26.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas QDEL's P/E ratio is -5.03. In terms of profitability, LMNX's ROE is +0.03%, compared to QDEL's ROE of -0.11%. Regarding short-term risk, LMNX is less volatile compared to QDEL. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check QDEL's competition here
LMNX vs AZTA Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, AZTA has a market cap of 1.6B. Regarding current trading prices, LMNX is priced at $36.99, while AZTA trades at $33.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas AZTA's P/E ratio is -10.38. In terms of profitability, LMNX's ROE is +0.03%, compared to AZTA's ROE of -0.04%. Regarding short-term risk, LMNX is less volatile compared to AZTA. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check AZTA's competition here
LMNX vs ATRC Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, ATRC has a market cap of 1.5B. Regarding current trading prices, LMNX is priced at $36.99, while ATRC trades at $30.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas ATRC's P/E ratio is -37.27. In terms of profitability, LMNX's ROE is +0.03%, compared to ATRC's ROE of -0.08%. Regarding short-term risk, LMNX is less volatile compared to ATRC. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check ATRC's competition here
LMNX vs NVCR Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, NVCR has a market cap of 1.4B. Regarding current trading prices, LMNX is priced at $36.99, while NVCR trades at $12.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas NVCR's P/E ratio is -8.30. In terms of profitability, LMNX's ROE is +0.03%, compared to NVCR's ROE of -0.45%. Regarding short-term risk, LMNX is less volatile compared to NVCR. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check NVCR's competition here
LMNX vs BLFS Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, BLFS has a market cap of 1.1B. Regarding current trading prices, LMNX is priced at $36.99, while BLFS trades at $22.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas BLFS's P/E ratio is -117.16. In terms of profitability, LMNX's ROE is +0.03%, compared to BLFS's ROE of -0.03%. Regarding short-term risk, LMNX is less volatile compared to BLFS. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check BLFS's competition here
LMNX vs PLSE Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, PLSE has a market cap of 1B. Regarding current trading prices, LMNX is priced at $36.99, while PLSE trades at $14.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas PLSE's P/E ratio is -15.02. In terms of profitability, LMNX's ROE is +0.03%, compared to PLSE's ROE of -0.71%. Regarding short-term risk, LMNX is less volatile compared to PLSE. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check PLSE's competition here
LMNX vs STAA Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, STAA has a market cap of 940.3M. Regarding current trading prices, LMNX is priced at $36.99, while STAA trades at $18.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas STAA's P/E ratio is -13.18. In terms of profitability, LMNX's ROE is +0.03%, compared to STAA's ROE of -0.18%. Regarding short-term risk, LMNX is less volatile compared to STAA. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check STAA's competition here
LMNX vs KMTS Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, KMTS has a market cap of 871.4M. Regarding current trading prices, LMNX is priced at $36.99, while KMTS trades at $16.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas KMTS's P/E ratio is -3.31. In terms of profitability, LMNX's ROE is +0.03%, compared to KMTS's ROE of +0.27%. Regarding short-term risk, LMNX is less volatile compared to KMTS. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check KMTS's competition here
LMNX vs ATRI Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, LMNX is priced at $36.99, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas ATRI's P/E ratio is 64.50. In terms of profitability, LMNX's ROE is +0.03%, compared to ATRI's ROE of +0.04%. Regarding short-term risk, LMNX is less volatile compared to ATRI. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check ATRI's competition here
LMNX vs ANGO Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, ANGO has a market cap of 370.2M. Regarding current trading prices, LMNX is priced at $36.99, while ANGO trades at $9.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas ANGO's P/E ratio is -10.98. In terms of profitability, LMNX's ROE is +0.03%, compared to ANGO's ROE of -0.18%. Regarding short-term risk, LMNX is less volatile compared to ANGO. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check ANGO's competition here
LMNX vs NYXH Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, NYXH has a market cap of 292.3M. Regarding current trading prices, LMNX is priced at $36.99, while NYXH trades at $7.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas NYXH's P/E ratio is -3.35. In terms of profitability, LMNX's ROE is +0.03%, compared to NYXH's ROE of -0.65%. Regarding short-term risk, LMNX is less volatile compared to NYXH. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check NYXH's competition here
LMNX vs OSUR Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, OSUR has a market cap of 248.7M. Regarding current trading prices, LMNX is priced at $36.99, while OSUR trades at $3.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas OSUR's P/E ratio is -7.92. In terms of profitability, LMNX's ROE is +0.03%, compared to OSUR's ROE of -0.08%. Regarding short-term risk, LMNX is less volatile compared to OSUR. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check OSUR's competition here
LMNX vs SMTI Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, SMTI has a market cap of 228M. Regarding current trading prices, LMNX is priced at $36.99, while SMTI trades at $25.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas SMTI's P/E ratio is -19.14. In terms of profitability, LMNX's ROE is +0.03%, compared to SMTI's ROE of -0.29%. Regarding short-term risk, LMNX is less volatile compared to SMTI. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check SMTI's competition here
LMNX vs STXS Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, STXS has a market cap of 201.7M. Regarding current trading prices, LMNX is priced at $36.99, while STXS trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas STXS's P/E ratio is -7.21. In terms of profitability, LMNX's ROE is +0.03%, compared to STXS's ROE of -2.17%. Regarding short-term risk, LMNX is less volatile compared to STXS. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check STXS's competition here
LMNX vs UTMD Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, UTMD has a market cap of 188.6M. Regarding current trading prices, LMNX is priced at $36.99, while UTMD trades at $58.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas UTMD's P/E ratio is 15.32. In terms of profitability, LMNX's ROE is +0.03%, compared to UTMD's ROE of +0.11%. Regarding short-term risk, LMNX is less volatile compared to UTMD. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check UTMD's competition here
LMNX vs PDEX Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, PDEX has a market cap of 162.5M. Regarding current trading prices, LMNX is priced at $36.99, while PDEX trades at $49.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas PDEX's P/E ratio is 18.05. In terms of profitability, LMNX's ROE is +0.03%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, LMNX is less volatile compared to PDEX. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check PDEX's competition here
LMNX vs KRMD Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, KRMD has a market cap of 162M. Regarding current trading prices, LMNX is priced at $36.99, while KRMD trades at $3.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas KRMD's P/E ratio is -29.25. In terms of profitability, LMNX's ROE is +0.03%, compared to KRMD's ROE of -0.30%. Regarding short-term risk, LMNX is less volatile compared to KRMD. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check KRMD's competition here
LMNX vs INFU Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, INFU has a market cap of 124.1M. Regarding current trading prices, LMNX is priced at $36.99, while INFU trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas INFU's P/E ratio is 39.45. In terms of profitability, LMNX's ROE is +0.03%, compared to INFU's ROE of +0.08%. Regarding short-term risk, LMNX is less volatile compared to INFU. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check INFU's competition here
LMNX vs ZJYL Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, ZJYL has a market cap of 103.7M. Regarding current trading prices, LMNX is priced at $36.99, while ZJYL trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas ZJYL's P/E ratio is 33.11. In terms of profitability, LMNX's ROE is +0.03%, compared to ZJYL's ROE of +0.13%. Regarding short-term risk, LMNX is less volatile compared to ZJYL. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check ZJYL's competition here
LMNX vs MBOT Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, MBOT has a market cap of 99.3M. Regarding current trading prices, LMNX is priced at $36.99, while MBOT trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas MBOT's P/E ratio is -4.27. In terms of profitability, LMNX's ROE is +0.03%, compared to MBOT's ROE of -0.85%. Regarding short-term risk, LMNX is less volatile compared to MBOT. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check MBOT's competition here
LMNX vs ZTEK Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, ZTEK has a market cap of 95.3M. Regarding current trading prices, LMNX is priced at $36.99, while ZTEK trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas ZTEK's P/E ratio is -13.00. In terms of profitability, LMNX's ROE is +0.03%, compared to ZTEK's ROE of -0.59%. Regarding short-term risk, LMNX is less volatile compared to ZTEK. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check ZTEK's competition here
LMNX vs AKYA Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, LMNX is priced at $36.99, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas AKYA's P/E ratio is -1.34. In terms of profitability, LMNX's ROE is +0.03%, compared to AKYA's ROE of -5.06%. Regarding short-term risk, LMNX is more volatile compared to AKYA. This indicates potentially higher risk in terms of short-term price fluctuations for LMNX.Check AKYA's competition here
LMNX vs OMIC Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, LMNX is priced at $36.99, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas OMIC's P/E ratio is -0.58. In terms of profitability, LMNX's ROE is +0.03%, compared to OMIC's ROE of -0.58%. Regarding short-term risk, LMNX and OMIC have similar daily volatility (0.05).Check OMIC's competition here
LMNX vs IGAP Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, LMNX is priced at $36.99, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas IGAP's P/E ratio is -10.52. In terms of profitability, LMNX's ROE is +0.03%, compared to IGAP's ROE of +3.93%. Regarding short-term risk, LMNX is less volatile compared to IGAP. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check IGAP's competition here
LMNX vs DXR Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, DXR has a market cap of 49.6M. Regarding current trading prices, LMNX is priced at $36.99, while DXR trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas DXR's P/E ratio is -111.11. In terms of profitability, LMNX's ROE is +0.03%, compared to DXR's ROE of +0.02%. Regarding short-term risk, LMNX is less volatile compared to DXR. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check DXR's competition here
LMNX vs WOK Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, WOK has a market cap of 46.9M. Regarding current trading prices, LMNX is priced at $36.99, while WOK trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas WOK's P/E ratio is -3.07. In terms of profitability, LMNX's ROE is +0.03%, compared to WOK's ROE of -0.30%. Regarding short-term risk, LMNX is less volatile compared to WOK. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check WOK's competition here
LMNX vs MLSS Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, MLSS has a market cap of 46.7M. Regarding current trading prices, LMNX is priced at $36.99, while MLSS trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas MLSS's P/E ratio is -9.92. In terms of profitability, LMNX's ROE is +0.03%, compared to MLSS's ROE of -0.83%. Regarding short-term risk, LMNX is less volatile compared to MLSS. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check MLSS's competition here
LMNX vs POCI Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, POCI has a market cap of 37.6M. Regarding current trading prices, LMNX is priced at $36.99, while POCI trades at $4.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas POCI's P/E ratio is -5.38. In terms of profitability, LMNX's ROE is +0.03%, compared to POCI's ROE of -0.54%. Regarding short-term risk, LMNX is less volatile compared to POCI. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check POCI's competition here
LMNX vs NEPH Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, NEPH has a market cap of 36.7M. Regarding current trading prices, LMNX is priced at $36.99, while NEPH trades at $3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas NEPH's P/E ratio is 43.25. In terms of profitability, LMNX's ROE is +0.03%, compared to NEPH's ROE of +0.09%. Regarding short-term risk, LMNX is less volatile compared to NEPH. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check NEPH's competition here
LMNX vs FEMY Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, FEMY has a market cap of 29.9M. Regarding current trading prices, LMNX is priced at $36.99, while FEMY trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas FEMY's P/E ratio is -1.01. In terms of profitability, LMNX's ROE is +0.03%, compared to FEMY's ROE of -3.92%. Regarding short-term risk, LMNX is less volatile compared to FEMY. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check FEMY's competition here
LMNX vs SDC Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, LMNX is priced at $36.99, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas SDC's P/E ratio is -0.03. In terms of profitability, LMNX's ROE is +0.03%, compared to SDC's ROE of -1.96%. Regarding short-term risk, LMNX is less volatile compared to SDC. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check SDC's competition here
LMNX vs NXGLW Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, NXGLW has a market cap of 26.1M. Regarding current trading prices, LMNX is priced at $36.99, while NXGLW trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas NXGLW's P/E ratio is -0.24. In terms of profitability, LMNX's ROE is +0.03%, compared to NXGLW's ROE of -0.63%. Regarding short-term risk, LMNX is more volatile compared to NXGLW. This indicates potentially higher risk in terms of short-term price fluctuations for LMNX.Check NXGLW's competition here
LMNX vs HBIO Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, HBIO has a market cap of 25.2M. Regarding current trading prices, LMNX is priced at $36.99, while HBIO trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas HBIO's P/E ratio is -0.44. In terms of profitability, LMNX's ROE is +0.03%, compared to HBIO's ROE of -1.10%. Regarding short-term risk, LMNX is less volatile compared to HBIO. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check HBIO's competition here
LMNX vs IVC Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, LMNX is priced at $36.99, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas IVC's P/E ratio is -0.79. In terms of profitability, LMNX's ROE is +0.03%, compared to IVC's ROE of -0.46%. Regarding short-term risk, LMNX is less volatile compared to IVC. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check IVC's competition here
LMNX vs RVP Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, RVP has a market cap of 21.1M. Regarding current trading prices, LMNX is priced at $36.99, while RVP trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas RVP's P/E ratio is -0.93. In terms of profitability, LMNX's ROE is +0.03%, compared to RVP's ROE of -0.27%. Regarding short-term risk, LMNX is less volatile compared to RVP. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check RVP's competition here
LMNX vs NXGL Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, NXGL has a market cap of 18.2M. Regarding current trading prices, LMNX is priced at $36.99, while NXGL trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas NXGL's P/E ratio is -5.28. In terms of profitability, LMNX's ROE is +0.03%, compared to NXGL's ROE of -0.63%. Regarding short-term risk, LMNX is less volatile compared to NXGL. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check NXGL's competition here
LMNX vs MHUA Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, MHUA has a market cap of 12.3M. Regarding current trading prices, LMNX is priced at $36.99, while MHUA trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas MHUA's P/E ratio is 0.97. In terms of profitability, LMNX's ROE is +0.03%, compared to MHUA's ROE of +0.09%. Regarding short-term risk, LMNX is less volatile compared to MHUA. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check MHUA's competition here
LMNX vs EKSO Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, EKSO has a market cap of 11.3M. Regarding current trading prices, LMNX is priced at $36.99, while EKSO trades at $4.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas EKSO's P/E ratio is -0.66. In terms of profitability, LMNX's ROE is +0.03%, compared to EKSO's ROE of -0.82%. Regarding short-term risk, LMNX is less volatile compared to EKSO. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check EKSO's competition here
LMNX vs LUCY Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, LUCY has a market cap of 9.6M. Regarding current trading prices, LMNX is priced at $36.99, while LUCY trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas LUCY's P/E ratio is 0.05. In terms of profitability, LMNX's ROE is +0.03%, compared to LUCY's ROE of -0.95%. Regarding short-term risk, LMNX is less volatile compared to LUCY. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check LUCY's competition here
LMNX vs POAI Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, POAI has a market cap of 8.2M. Regarding current trading prices, LMNX is priced at $36.99, while POAI trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas POAI's P/E ratio is -0.56. In terms of profitability, LMNX's ROE is +0.03%, compared to POAI's ROE of -5.91%. Regarding short-term risk, LMNX is less volatile compared to POAI. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check POAI's competition here
LMNX vs STSS Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, STSS has a market cap of 6.3M. Regarding current trading prices, LMNX is priced at $36.99, while STSS trades at $6.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas STSS's P/E ratio is N/A. In terms of profitability, LMNX's ROE is +0.03%, compared to STSS's ROE of -0.99%. Regarding short-term risk, LMNX is less volatile compared to STSS. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check STSS's competition here
LMNX vs NSTG Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, LMNX is priced at $36.99, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas NSTG's P/E ratio is -0.03. In terms of profitability, LMNX's ROE is +0.03%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, LMNX is less volatile compared to NSTG. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check NSTG's competition here
LMNX vs GCTK Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, GCTK has a market cap of 4.3M. Regarding current trading prices, LMNX is priced at $36.99, while GCTK trades at $7.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas GCTK's P/E ratio is N/A. In terms of profitability, LMNX's ROE is +0.03%, compared to GCTK's ROE of +3.93%. Regarding short-term risk, LMNX is less volatile compared to GCTK. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check GCTK's competition here
LMNX vs GMVD Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, LMNX is priced at $36.99, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas GMVD's P/E ratio is -0.01. In terms of profitability, LMNX's ROE is +0.03%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, LMNX is less volatile compared to GMVD. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check GMVD's competition here
LMNX vs GMVDW Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, LMNX is priced at $36.99, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas GMVDW's P/E ratio is N/A. In terms of profitability, LMNX's ROE is +0.03%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, LMNX is less volatile compared to GMVDW. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check GMVDW's competition here
LMNX vs AVGR Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, LMNX is priced at $36.99, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas AVGR's P/E ratio is -0.05. In terms of profitability, LMNX's ROE is +0.03%, compared to AVGR's ROE of -54.25%. Regarding short-term risk, LMNX is less volatile compared to AVGR. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check AVGR's competition here
LMNX vs LUCYW Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, LUCYW has a market cap of 150.2K. Regarding current trading prices, LMNX is priced at $36.99, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas LUCYW's P/E ratio is N/A. In terms of profitability, LMNX's ROE is +0.03%, compared to LUCYW's ROE of -0.95%. Regarding short-term risk, LMNX is less volatile compared to LUCYW. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check LUCYW's competition here
LMNX vs ATRS Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, ATRS has a market cap of 0. Regarding current trading prices, LMNX is priced at $36.99, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas ATRS's P/E ratio is 14.95. In terms of profitability, LMNX's ROE is +0.03%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, LMNX is less volatile compared to ATRS. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check ATRS's competition here
LMNX vs APR Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, APR has a market cap of 0. Regarding current trading prices, LMNX is priced at $36.99, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas APR's P/E ratio is 22.59. In terms of profitability, LMNX's ROE is +0.03%, compared to APR's ROE of +9.81%. Regarding short-term risk, LMNX and APR have similar daily volatility (0.05).Check APR's competition here
LMNX vs IIN Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, IIN has a market cap of 0. Regarding current trading prices, LMNX is priced at $36.99, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas IIN's P/E ratio is 226.45. In terms of profitability, LMNX's ROE is +0.03%, compared to IIN's ROE of -0.00%. Regarding short-term risk, LMNX is less volatile compared to IIN. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check IIN's competition here
LMNX vs HRC Comparison July 2025
LMNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMNX stands at 0. In comparison, HRC has a market cap of 0. Regarding current trading prices, LMNX is priced at $36.99, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMNX currently has a P/E ratio of N/A, whereas HRC's P/E ratio is 41.92. In terms of profitability, LMNX's ROE is +0.03%, compared to HRC's ROE of +0.14%. Regarding short-term risk, LMNX is less volatile compared to HRC. This indicates potentially lower risk in terms of short-term price fluctuations for LMNX.Check HRC's competition here